𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A review of major Crohn’s disease susceptibility genes and their role in disease pathogenesis

✍ Scribed by Meghan Barrett; Sathees B. Chandra


Publisher
The Genetics Society of Korea
Year
2011
Tongue
English
Weight
272 KB
Volume
33
Category
Article
ISSN
1976-9571

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Confirmation of the role of ATG16l1 as a
✍ J.R. Fraser Cummings; Rachel Cooney; Saad Pathan; Carl A. Anderson; Jeffrey C. B 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB

Background: A German genome-wide nonsynonymous single nucleotide polymorphism (nsSNP) association study identified ATG16L1 as a Crohn's disease (CD) susceptibility gene. The association appeared to be confined to the nsSNP rs2241880 and was confirmed in 2 German independent case-control collections

Genetic susceptibility has a more import
✍ Lissy de Ridder; Rinse K. Weersma; Gerard Dijkstra; Gerrit van der Steege; Marc 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 113 KB 👁 1 views

Background: Genetic susceptibility may play a more important role in the etiology of early-onset inflammatory bowel disease (IBD) than in late-onset IBD, and therefore pediatric-onset IBD patients can be expected to have a higher frequency of gene mutations. We aimed to determine genotypes and pheno

NELL1, NCF4, and FAM92B genes are not ma
✍ Devendra K. Amre; David R. Mack; David Israel; Alfreda Krupoves; Irina Costea; P 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 743 KB

Background: Genome-wide association studies (GWAS) and replication studies have shown conflicting associations between the NELL1, NCF4, and FAM92B genes and susceptibility for Crohn's disease (CD). We sought to examine whether these genes were associated with CD in Canadian children and young adults

Changing shape of disease: Nonalcoholic
✍ Christopher E. McGowan; Patricia Jones; Millie D. Long; A. Sidney Barritt IV 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 2 views

Background: With improvements in therapy for inflammatory bowel disease (IBD) and changes in the prevalence of obesity, the phenotype of Crohn's disease (CD) is changing. These changes may herald an increase in the incidence of nonalcoholic fatty liver disease (NAFLD) in this population. Methods: O